# A Study of GSK573719 in Healthy Japanese Male Subjects

> **NCT01013974** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 48 (actual)

## Conditions studied

- Pulmonary Disease, Chronic Obstructive

## Interventions

- **DRUG:** GSK573719 250 μg
- **DRUG:** GSK573719 500 μg
- **DRUG:** GSK573719 1000 μg
- **DRUG:** GSK573719 matching Placebo

## Key facts

- **NCT ID:** NCT01013974
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-10-05
- **Primary completion:** 2009-12-18
- **Final completion:** 2009-12-18
- **Target enrollment:** 48 (ACTUAL)
- **Last updated:** 2017-08-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01013974

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01013974, "A Study of GSK573719 in Healthy Japanese Male Subjects". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT01013974. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*